FULC vs. BIOX
FULC (Fulcrum Therapeutics, Inc.) and BIOX (Bioceres Crop Solutions Corp.) are both stocks. FULC operates in Biotechnology (Healthcare), while BIOX operates in Agricultural Inputs (Basic Materials). Over the past 5 years, FULC returned -15.20%/yr vs -51.60%/yr for BIOX. At a 0.14 correlation, their price movements are largely independent.
Performance
FULC vs. BIOX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FULC achieves a -65.96% return, which is significantly higher than BIOX's -71.60% return.
FULC
- 1D
- 2.12%
- 1M
- -41.40%
- YTD
- -65.96%
- 6M
- -67.35%
- 1Y
- -46.30%
- 3Y*
- 7.03%
- 5Y*
- -15.20%
- 10Y*
- —
BIOX
- 1D
- -2.00%
- 1M
- -10.12%
- YTD
- -71.60%
- 6M
- -72.44%
- 1Y
- -91.82%
- 3Y*
- -69.97%
- 5Y*
- -51.60%
- 10Y*
- —
FULC vs. BIOX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
FULC Fulcrum Therapeutics, Inc. | -65.96% | 140.64% | -30.37% | -7.28% | -58.85% | 51.07% | -29.63% | 14.76% |
BIOX Bioceres Crop Solutions Corp. | -71.60% | -78.45% | -55.72% | 14.13% | -14.92% | 128.06% | 22.80% | -16.55% |
Correlation
The correlation between FULC and BIOX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jul 18, 2019 | 0.14 |
Fundamentals
FULC:
$293.43M
BIOX:
$23.66M
FULC:
-$1.15
BIOX:
-$3.84
FULC:
0.88
BIOX:
0.35
FULC:
$0.00
BIOX:
$263.71M
FULC:
$0.00
BIOX:
$97.66M
FULC:
-$78.37M
BIOX:
-$1.32M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FULC vs. BIOX — Risk / Return Rank
FULC
BIOX
FULC vs. BIOX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and Bioceres Crop Solutions Corp. (BIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FULC | BIOX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.44 | ||
| Sortino ratioReturn per unit of downside risk | +2.43 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 0.72 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | -0.99 | +0.40 |
| Martin ratioReturn relative to average drawdown | -1.34 | -1.27 | -0.07 |
Loading charts...
Drawdowns
FULC vs. BIOX - Drawdown Comparison
The maximum FULC drawdown since its inception was -92.70%, smaller than the maximum BIOX drawdown of -97.68%. Use the drawdown chart below to compare losses from any high point for FULC and BIOX.
Loading charts...
Drawdown Indicators
| FULC | BIOX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.70% | -97.68% | +4.98% |
Max Drawdown (1Y)Largest decline over 1 year | -78.49% | -92.57% | +14.08% |
Max Drawdown (3Y)Largest decline over 3 years | -79.08% | -97.33% | +18.25% |
Max Drawdown (5Y)Largest decline over 5 years | -92.70% | -97.68% | +4.98% |
Current DrawdownCurrent decline from peak | -87.57% | -97.68% | +10.11% |
Average DrawdownAverage peak-to-trough decline | -62.83% | -36.45% | -26.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.55% | 72.42% | -37.87% |
Volatility
FULC vs. BIOX - Volatility Comparison
Fulcrum Therapeutics, Inc. (FULC) has a higher volatility of 74.34% compared to Bioceres Crop Solutions Corp. (BIOX) at 17.36%. This indicates that FULC's price experiences larger fluctuations and is considered to be riskier than BIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FULC | BIOX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 74.34% | 17.36% | +56.98% |
Volatility (6M)Calculated over the trailing 6-month period | 87.06% | 83.10% | +3.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.81% | 102.00% | -2.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 111.35% | 63.86% | +47.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.66% | 64.89% | +46.77% |
Dividends
FULC vs. BIOX - Dividend Comparison
Neither FULC nor BIOX has paid dividends to shareholders.
Financials
FULC vs. BIOX - Financials Comparison
This section allows you to compare key financial metrics between Fulcrum Therapeutics, Inc. and Bioceres Crop Solutions Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
FULC and BIOX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FULC has higher volatility (74.34%) compared to BIOX (17.36%). In terms of maximum drawdown, FULC dropped -92.70% vs BIOX's -97.68%.
FULC currently has the higher Sharpe Ratio (-0.47 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FULC and BIOX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer